Stay updated on FIGHT: FPA144 in mFOLFOX6 Clinical Trial
Sign up to get notified when there's something new on the FIGHT: FPA144 in mFOLFOX6 Clinical Trial page.

Latest updates to the FIGHT: FPA144 in mFOLFOX6 Clinical Trial page
- Check4 days agoChange DetectedTwo screenshots depict the same ClinicalTrials.gov record for NCT03694522 with no detectable additions or deletions. The study's core details (title, objectives, endpoints, eligibility criteria, and locations) appear unchanged.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check33 days agoChange DetectedUpdated version to v3.2.0 and added a government operating-status notice for NIH Clinical Center, directing users to cc.nih.gov and opm.gov.SummaryDifference2%

- Check40 days agoChange DetectedAdds version v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) plus an older version tag (v3.0.2).SummaryDifference0.2%

- Check54 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the Back to Top link was removed.SummaryDifference0.1%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check68 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, particularly in South Korea and Turkey, as well as the introduction of topics related to drug safety and counterfeit drugs. The revision number has also been updated to v3.0.0.SummaryDifference23%

Stay in the know with updates to FIGHT: FPA144 in mFOLFOX6 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FIGHT: FPA144 in mFOLFOX6 Clinical Trial page.